美股夜盘 | 制药股上涨，TNFA涨超11%，诺和诺德涨超7%，Tilray涨超5%
8月18日（周一），美股夜盘制药股上涨，TNFA涨超11%，诺和诺德涨超7%，Tilray涨超5%，CGTX、爵士制药涨超3%。
消息方面：
FDA批准诺和诺德的减肥药Wegovy用于治疗伴有中重度肝纤维化的非肝硬化型MASH患者。这一决定使Wegovy成为美国首个获批治疗该严重肝病的药物，满足了约1490万美国成年患者的需求。临床试验显示Wegovy在改善肝纤维化和炎症方面显著优于安慰剂。此次获批进一步巩固了诺和诺德在GLP-1市场的领先地位，并为其开辟了重要的新增长点。
Jazz Pharmaceuticals 已获得 FDA 批准，推出 Modeyso（dordaviprone），用于治疗罕见脑癌弥漫性中线胶质瘤（伴有 H3 K27M 突变），这种癌症主要影响年轻人。该药物通过以 9.35 亿美元收购 Chimerix 获得，被批准用于一岁及以上在先前治疗后癌症已进展的患者。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10